These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 35307646)

  • 1. MCM2 promotes the proliferation, migration and invasion of cholangiocarcinoma cells by reducing the p53 signaling pathway.
    Wang CL; Liu XY; Wang YH; Zhang Z; Wang ZD; Zhou GQ
    Yi Chuan; 2022 Mar; 44(3):230-244. PubMed ID: 35307646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iodine-125 seed inhibits proliferation and promotes apoptosis of cholangiocarcinoma cells by inducing the ROS/p53 axis.
    Kang F; Wu J; Hong L; Zhang P; Song J
    Funct Integr Genomics; 2024 Jun; 24(3):114. PubMed ID: 38862667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HSDL2 knockdown promotes the progression of cholangiocarcinoma by inhibiting ferroptosis through the P53/SLC7A11 axis.
    Ma S; Ma Y; Qi F; Lei J; Chen F; Sun W; Wang D; Zhou S; Liu Z; Lu Z; Zhang D
    World J Surg Oncol; 2023 Sep; 21(1):293. PubMed ID: 37718459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA MIR22HG inhibits cell proliferation and migration in cholangiocarcinoma by negatively regulating the Wnt/β-catenin signaling pathway.
    Hu X; Tan Z; Yang Y; Yang P
    J Gene Med; 2019 May; 21(5):e3085. PubMed ID: 30856284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in chemokine receptor CCR5 activity influence tumor cell biology in human cholangiocarcinoma cell lines.
    Yang J; Sontag D; Gong Y; Minuk GY
    Ann Hepatol; 2021; 21():100265. PubMed ID: 33045415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulated LASP-1 correlates with a malignant phenotype and its potential therapeutic role in human cholangiocarcinoma.
    Zhang H; Li Z; Chu B; Zhang F; Zhang Y; Ke F; Chen Y; Xu Y; Liu S; Zhao S; Liang H; Weng M; Wu X; Li M; Wu W; Quan Z; Liu Y; Zhang Y; Gong W
    Tumour Biol; 2016 Jun; 37(6):8305-15. PubMed ID: 26729195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
    Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S
    BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of ATF3 repression of epithelial-mesenchymal transition and suppression of cell viability in cholangiocarcinoma via p53 signal pathway.
    You Z; Xu J; Li B; Ye H; Chen L; Liu Y; Xiong X
    J Cell Mol Med; 2019 Mar; 23(3):2184-2193. PubMed ID: 30648816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
    Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
    Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulated circular RNA hsa_circ_0001649 regulates proliferation, migration and invasion in cholangiocarcinoma cells.
    Xu Y; Yao Y; Zhong X; Leng K; Qin W; Qu L; Cui Y; Jiang X
    Biochem Biophys Res Commun; 2018 Feb; 496(2):455-461. PubMed ID: 29337065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
    Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L
    Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LINC01410 promotes cell proliferation and migration of cholangiocarcinoma through modulating miR-124-3p/SMAD5 axis.
    Jiang T; Wang C; Zhu Y; Han H
    J Gene Med; 2020 Jun; 22(6):e3162. PubMed ID: 31951299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122.
    Zhu H; Mi Y; Jiang X; Zhou X; Li R; Wei Z; Jiang H; Lu J; Sun X
    J Cancer Res Clin Oncol; 2016 May; 142(5):969-80. PubMed ID: 26825606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA FENDRR represses proliferation, migration and invasion through suppression of survivin in cholangiocarcinoma cells.
    Qin X; Lu M; Zhou Y; Li G; Liu Z
    Cell Cycle; 2019 Apr; 18(8):889-897. PubMed ID: 30983519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma.
    Gao J; Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Cui Y; Zhong X
    Pathol Res Pract; 2020 Jan; 216(1):152733. PubMed ID: 31812439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA myocardial infarction associated transcript promotes the proliferation of cholangiocarcinoma cells by targeting miR-551b-3p/CCND1 axis.
    Chang W; Wang Y; Li W; Geng Z
    Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):1067-1075. PubMed ID: 32064660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZHX1 Promotes the Proliferation, Migration and Invasion of Cholangiocarcinoma Cells.
    Kwon RJ; Han ME; Kim JY; Liu L; Kim YH; Jung JS; Oh SO
    PLoS One; 2016; 11(11):e0165516. PubMed ID: 27835650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA CDR1as Exerts Oncogenic Properties Partially through Regulating MicroRNA 641 in Cholangiocarcinoma.
    Li D; Tang Z; Gao Z; Shen P; Liu Z; Dang X
    Mol Cell Biol; 2020 Jul; 40(15):. PubMed ID: 32423991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic Role of the NFATC2/NEDD4/FBP1 Axis in Cholangiocarcinoma.
    Zhao W; Zhao J; Li K; Hu Y; Yang D; Tan B; Shi J
    Lab Invest; 2023 Sep; 103(9):100193. PubMed ID: 37285922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.